Maintenance of patency after thrombolysis in stenotic coronary arteries requires combined inhibition of thrombin and platelets
- 31 July 1993
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 22 (1), 296-301
- https://doi.org/10.1016/0735-1097(93)90847-t
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Principles and practice of coronary thrombolysis and conjunctive treatmentThe American Journal of Cardiology, 1991
- Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarctionThe American Journal of Cardiology, 1990
- Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparationJournal of the American College of Cardiology, 1990
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- Platelets and Thrombolytic TherapyNew England Journal of Medicine, 1990
- Mechanisms of arterial thrombosis in nonparallel streamlines: platelet thrombi grow on the apex of stenotic severely injured vessel wall. Experimental study in the pig model.Journal of Clinical Investigation, 1989
- Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysisJournal of the American College of Cardiology, 1986
- Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions.Circulation, 1984
- Platelet aggregation in partially obstructed vessels and its elimination with aspirin.Circulation, 1976
- Some species differences in fibrinolysis and blood coagulationJournal of Biomedical Materials Research, 1971